Bipolar androgen therapy followed by enzalutamide in castrate-resistant metastatic prostate cancer patients resulted in significantly greater survival compared to enzalutamide alone.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.